Bar Harbor Trust Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,635
Closed -$240K 92
2022
Q1
$240K Hold
4,635
0.07% 117
2021
Q4
$273K Buy
+4,635
New +$230K 0.07% 112
2020
Q4
Sell
-5,825
Closed -$203K 127
2020
Q3
$203K Sell
5,825
-1,217
-17% -$42.7K 0.09% 114
2020
Q2
$219K Sell
7,042
-5,307
-43% -$180K 0.1% 110
2020
Q1
$382K Sell
12,349
-14,689
-54% -$501K 0.27% 63
2019
Q4
$1M Buy
+27,038
New +$963K 0.4% 50
2013
Q3
Sell
-184,263
Closed -$4.89M 85
2013
Q2
$4.89M Buy
+184,263
New +$5.09M 2.57% 15

Other funds holding PFE

Bar Harbor Trust Services's PFE Position: Q2 2022 in Review

Bar Harbor Trust Services sold out of Pfizer (PFE) in Q2 2022, closing a stake of 4,635 shares — an estimated $240K sold.

Bar Harbor Trust Services first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $4.89M in Q2 2013. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • Bar Harbor Trust Services reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
  • Bar Harbor Trust Services sold 4,635 Pfizer shares in Q2 2022, an estimated $240K.
  • Bar Harbor Trust Services first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
  • Bar Harbor Trust Services's Pfizer position peaked at $4.89M in Q2 2013.
  • 3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Bar Harbor Trust Services's 13F filing for Q2 2022.